Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009254
Filing Date
2023-05-11
Accepted
2023-05-11 07:09:58
Documents
55
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20230331x10q.htm   iXBRL 10-Q 1134284
2 EX-31.1 mist-20230331xex31d1.htm EX-31.1 12311
3 EX-31.2 mist-20230331xex31d2.htm EX-31.2 12462
4 EX-32.1 mist-20230331xex32d1.htm EX-32.1 9432
  Complete submission text file 0001558370-23-009254.txt   4905190

Data Files

Seq Description Document Type Size
5 EX-101.SCH mist-20230331.xsd EX-101.SCH 35359
6 EX-101.CAL mist-20230331_cal.xml EX-101.CAL 31004
7 EX-101.DEF mist-20230331_def.xml EX-101.DEF 125409
8 EX-101.LAB mist-20230331_lab.xml EX-101.LAB 308779
9 EX-101.PRE mist-20230331_pre.xml EX-101.PRE 230751
49 EXTRACTED XBRL INSTANCE DOCUMENT mist-20230331x10q_htm.xml XML 906198
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 23908778
SIC: 2834 Pharmaceutical Preparations